ADVANCE - Action in Diabetes and Vascular Disease: Preterax and Diamicron - MR Controlled Evaluation
Latest Information Update: 28 Feb 2023
Price :
$35 *
At a glance
- Drugs Gliclazide (Primary) ; Perindopril/indapamide (Primary) ; Antihyperglycaemics
- Indications Cardiovascular disorders; Diabetic angiopathies; Diabetic complications; Diabetic nephropathies; Diabetic retinopathy; Hypertension; Myocardial infarction; Proteinuria; Stroke; Type 2 diabetes mellitus; Unstable angina pectoris
- Focus Registrational; Therapeutic Use
- Acronyms ADVANCE
- Sponsors Servier
- 17 Feb 2023 Results of post hoc analysis published in the Hypertension
- 01 Aug 2022 Results published in the Clinical Journal of The American Society of Nephrology: CJASN
- 01 Aug 2021 Results published in the Diabetes, Obesity and Metabolism